(Q45076097)

9 December 2017

title

Refractory acute lymphocytic leukemia: response to aclacinomycin A and VP-16-213. (English)

1 reference

acute lymphocytic leukemia

9 December 2017

main subject

1 reference

Rowe JM

1

1 reference

9 December 2017

Chang AY

series ordinal

2

1 reference

9 December 2017

Bennett JM

series ordinal

3

1 reference

9 December 2017

publication date

1 November 1989

1 reference

9 December 2017

published in

Hematological Oncology

1 reference

9 December 2017

volume

7

1 reference

9 December 2017

issue

6

1 reference

9 December 2017

page(s)

405-410

1 reference

A phase II trial of VP 16-213 in adults with refractory acute myeloid leukemia. An Eastern Cooperative Oncology Group study

9 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900070603

7 January 2021

Aggressive combination chemotherapy of bone marrow relapse in childhood acute lymphoblastic leukemia containing aclacinomycin-A: a multicentric trial.

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900070603

7 January 2021

Aclarubicin (aclacinomycin A) in the treatment of relapsing acute leukaemias

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900070603

7 January 2021

Toxicity and response criteria of the Eastern Cooperative Oncology Group

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900070603

7 January 2021

Single-agent and combination chemotherapy with etoposide in the acute leukemias of childhood

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900070603

7 January 2021

Possible differentiation of human acute myeloblastic leukemia cells by daily and intermittent administration of aclacinomycin-A

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900070603

7 January 2021

Induction of erythroid differentiation by the anthracycline antitumor antibiotics, aclacinomycin A, musettamycin and marcellomycin

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900070603

7 January 2021

A phase II study of aclacinomycin A in acute leukemia in adults

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900070603

7 January 2021

Identifiers

DOI

10.1002/HON.2900070603

1 reference

9 December 2017

1 reference